Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: J Neurochem. 2013 Oct 21;128(2):294–304. doi: 10.1111/jnc.12444

Table 1.

Subject demographic

Group Mean ± SEM age (years) Sex Mean ± SEM PMI (h) Median Braak Score
NC 86.3 ± 1.4 N=15; 4M, 11W 2.8 ± 0.2 I
PCAD 85.8 ± 1.7a N=14; 3M, 11W 2.8 ± 0.2 Vc
MCI 91.0 ± 1.9a,b N=7; 2M, 5W 2.6 ± 0.2 IVc
LAD 80.8 ± 1.4a N=15; 7M, 8W 3.6 ± 0.4 VIc
DC 68.9 ± 4.8 N=12; 7M, 5W 3.5 ± 0.4 IIc
a

p < 0.05 compared to DC

b

p < 0.05 compared to LAD

c

p ≤ 0.05 compared to NC

NC = age –matched normal control; MCI = mild cognitive impairment; PCAD = preclinical Alzheimer’s disease; LAD = late-stage Alzheimer’s disease; DC = diseased control; PMI=postmortem interval;

HHS Vulnerability Disclosure